Tag: clinical drug trial

Pilot clinical drug trial for treatment of infantile spasms

November 9, 2021

The first patient in an AC-21-024 study, a pilot clinical trial of tricaprilin for the treatment of Infantile Spasms, has been enrolled by Cerecin, a clinical-stage biotechnology company developing ketogenic agents as potential neurotherapeutics. Tricaprilin is an investigational oral drug under development for several neurological conditions, including migraine and epilepsy, and is designed to induce ketosis. In October 2020, Cerecin received […]

Continue Reading